Page 121 - Read Online
P. 121

Page 14 of 14                 Obeid et al. Vessel Plus 2022;6:43  https://dx.doi.org/10.20517/2574-1209.2021.136

               57.      Mehra MR. The burden of haemocompatibility with left ventricular assist systems: a complex weave. Eur Heart J 2019;40:673-7.
                   DOI  PubMed
               58.      Pedde D, Soltani S, Stein J, et al. Impact of preoperative atrial fibrillation on thromboembolic events and pump thrombosis in long-
                   term left ventricular assist device therapy. Eur J Cardiothorac Surg 2020;57:325-30.  DOI  PubMed
               59.      Oezpeker C, Zittermann A, Pühler T, Ensminger S, Gummert JF, Morshuis M. Permanent atrial fibrillation and 2 year clinical
                   outcomes in patients with a left ventricular assist device implant. ASAIO Journal 2017;63:419-24.  DOI  PubMed
               60.      Hollis IB, Doligalski CT, Jennings DJ. Pharmacotherapy for durable left ventricular assist devices. Pharmacotherapy 2021;41:14-27.
                   DOI  PubMed
               61.      Adatya S, Bennett MK. Anticoagulation management in mechanical circulatory support. J Thorac Dis 2015;7:2129-38.  DOI  PubMed
                   PMC
               62.      Netuka I, Ivák P, Tučanová Z, et al. Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow
                   circulatory pump-the MAGENTUM 1 study. J Heart Lung Transplant 2018;37:579-86.  DOI  PubMed
               63.      Deng MC, Edwards LB, Hertz MI, et al. Mechanical circulatory support device database of the international society for heart and lung
                   transplantation: second annual report--2004. J Heart Lung Transplant 2004;23:1027-34.  DOI  PubMed
               64.      Deng MC, Edwards LB, Hertz MI, et al. International Society for Heart and Lung Transplantation. Mechanical circulatory support
                   device database of the International Society for Heart and Lung Transplantation: third annual report--2005. J Heart Lung Transplant
                   2005;24:1182-7.  DOI  PubMed
               65.      Zhang RS, Hanff TC, Peters CJ, et al. Left ventricular assist device as a bridge to recovery: single center experience of successful
                   device explantation. ASAIO J 2022;68:822-8.  DOI  PubMed
               66.      Antonides CFJ, Schoenrath F, de By TMMH, et al. EUROMACS investigators. Outcomes of patients after successful left ventricular
                   assist device explantation: a EUROMACS study. ESC Heart Fail 2020;7:1085-94.  DOI  PubMed  PMC
               67.      Miyagawa S, Toda K, Nakamura T, et al. Building a bridge to recovery: the pathophysiology of LVAD-induced reverse modeling in
                   heart failure. Surg Today 2016;46:149-54.  DOI  PubMed
               68.      Maybaum S, Mancini D, Xydas S, et al. LVAD Working Group. Cardiac improvement during mechanical circulatory support: a
                   prospective multicenter study of the LVAD Working Group. Circulation 2007;115:2497-505.  DOI  PubMed
               69.      Klotz S, Jan Danser AH, Burkhoff D. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling
                   process. Prog Biophys Mol Biol 2008;97:479-96.  DOI  PubMed
   116   117   118   119   120   121   122   123   124   125   126